Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Leading Healthy Eating and Activity Promotion Program

for
Cancer Survivor, Cancer, Oncology
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18 - 70+

Code: NCT06868524

Recruiting

Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer

for
Advanced Cancer, Metastatic Cancer
Location: Manchester NH, Concord NH, New York NY, Spartanburg SC,
Sponsor: Alliance Foundation Trials, LLC.

Sex: All

Age: 21+

Code: NCT06963723

Recruiting

Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions

for
Malignant Skin Neoplasm, Skin Disorder, Skin Neoplasm
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT07213154

Recruiting

Alternative Physical Activity Strategies for Breast Cancer Survivors

for
Breast Cancer, Insulin Resistance, Cardiometabolic Risk Factors
Location: Toronto
Sponsor: University of Toronto

Sex: Female

Age: 0+

Code: NCT06633380

Recruiting

Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety in Rural Older Cancer Survivors

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07290543

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Factors Associated With Breast Cancer Risks and Outcomes

for
Breast Cancer
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18+

Code: NCT07294703

Recruiting

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

for
Lymphoma, Malignant Solid Neoplasm
Location: Lake Success NY, Chesapeake VA, Newark DE, Scranton PA,
Sponsor: University of Rochester

Sex: All

Age: 18+

Code: NCT05006482

Phase 3, Recruiting

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: New Haven CT, Philadelphia PA, Baltimore MD, Fairfax VA,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT07205718

Phase 1, Phase 2, Recruiting

A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

for
Advanced/Metastatic Solid Tumors
Location: Fairfax VA, Pittsburgh PA, Ann Arbor MI, Houston TX,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT07141706

Phase 1, Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

for
Melanoma (Skin Cancer),
Location: Lake Success NY, Fairfax VA, Rochester NY, Detroit MI,
Sponsor: Aminex Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07287917

Phase 1, Phase 2, Recruiting

A Mindfulness-Based Stress Reduction Program for Improving Mental Health Outcomes for Underserved Cancer Patients in Minnesota

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 0+

Code: NCT07291011

Recruiting

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

for
Nausea, Vomiting,
Location: New York NY, Tamarac FL, Savannah GA, Charlotte NC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07169851

Phase 2, Recruiting

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

for
Breast Cancer
Location: Boston MA, Newton MA, Waterford CT, Guilford CT,
Sponsor: Pfizer

Sex: All

Age: 18 - 70+

Code: NCT07062965

Phase 3, Recruiting

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

for
Solid Tumors, Advanced Solid Tumor
Location: Fairfax VA, Houston TX, San Antonio TX
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07181681

Phase 1, Recruiting

Improving Consent Experiences in Clinical Trials

for
Cancer
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07293520

Recruiting

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

for
Advanced Solid Tumors
Location: New York NY, Pittsburgh PA
Sponsor: AskGene Pharma, Inc.

Sex: All

Age: 18+

Code: NCT05867420

Phase 1, Phase 2, Recruiting

Weight Management After Cancer for Survivors in Rural Communities

for
Breast Cancer Survivorship, Weight Management,
Location: Smithfield NC, Henderson NC, Lumberton NC, Durham NC,
Sponsor: Duke University

Sex: Female

Age: 18+

Code: NCT07426952

Recruiting

Supporting Health Including Endocrine Treatment for Long Duration

for
Breast Cancer, Breast Cancer - Female, Breast Carcinoma,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: Female

Age: 18 - 49

Code: NCT07482384

Recruiting

Safety and Tolerability of HTI-1066 in Subjects With Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Scottsdale AZ
Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Sex: All

Age: 18+

Code: NCT03398720

Phase 1, Recruiting

Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer

for
Cancer, Solid Tumor Cancer, Pediatric Acute Myeloid Leukemia,
Location: Chicago IL
Sponsor: Tempus AI

Sex: All

Age: 0+

Code: NCT07756034

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial